CLBT
Cellebrite DI Ltd.
CLBT trails on the overall score without a compensating advantage in the available component scores.
MSFT
Microsoft Corporation
MSFT has the edge over CLBT overall, supported by stronger valuation and stronger modeled upside.
CLBT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Strong | |
| Strong |
CLBT's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
MSFT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Strong |
MSFT's revenue, profitability, cash flow and balance sheet are all currently healthy.
CLBT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.1x | $1.64 | -85% |
| Forward | 33x | $10.89 | — |
| Fair | 44x | $10.10 | -7.3% |
| Current | 47x | $10.89 | — |
| Expensive | 62x | $14.35 | +32% |
Historical ranges are pointers, not guarantees.
CLBT's PE is in its fair range at 47x, but its recent earnings include one-off gains. If earnings grow as analysts expect, today's price would be 33x next year's earnings.
MSFT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 25x | $523 | — |
| Cheap | 27x | $525 | +0.4% |
| Current | 27x | $523 | — |
| Fair | 34x | $652 | +25% |
| Expensive | 37x | $711 | +36% |
Historical ranges are pointers, not guarantees.
MSFT has the edge over CLBT in the historical PE scenario, which offers more potential upside but is not a forecast.
CLBT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for CLBT, but weaker profitability.
MSFT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Moderate | |
| High |
MSFT has the edge over CLBT on the outlook, with more favorable profitability expectations.
CLBT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.33 | +46% |
| Q2 2026 | $0.23 | +$0.99 |
| Q1 2026 | $0.29 | +$1.25 |
| Q4 2025 | $0.31 | +$1.70 |
| Q3 2025 | $0.31 | +$1.86 |
| Q2 2025 | -$0.76 | -$0.24 |
| Q1 2025 | -$0.96 | -$0.39 |
| Q4 2024 | -$1.39 | -$0.96 |
| Q3 2024 | -$1.55 | -$1.23 |
CLBT has returned to profit: it earned $0.23 per share over the past year, after losing money the year before. Its recent earnings include one-off gains.
MSFT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $20.79 | +8.6% |
| Q3 2026 | $19.15 | +36% |
| Q2 2026 | $17.95 | +32% |
| Q1 2026 | $16.80 | +30% |
| Q4 2025 | $15.99 | +29% |
| Q3 2025 | $14.06 | +16% |
| Q2 2025 | $13.64 | +16% |
| Q1 2025 | $12.93 | +12% |
| Q4 2024 | $12.41 | +12% |
MSFT has the edge over CLBT on earnings, with more consistent year-over-year improvement.
CLBT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $131.1M | +16% |
| Q1 2026 | $128.3M | +19% |
| Q4 2025 | $128.8M | +18% |
| Q3 2025 | $126M | +18% |
| Q2 2025 | $113.3M | +18% |
| Q1 2025 | $107.5M | +20% |
| Q4 2024 | $109M | +17% |
| Q3 2024 | $106.9M | +27% |
CLBT has the edge over MSFT on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 5.8% | -6.9 points |
| Q1 2026 | 7.1% | -4.3 points |
| Q4 2025 | 16% | +1.7 points |
| Q3 2025 | 15% | -3.1 points |
| Q2 2025 | 13% | -0.3 points |
| Q1 2025 | 11% | +1.1 points |
| Q4 2024 | 14% | -1.7 points |
| Q3 2024 | 18% | +2.2 points |
CLBT's operating margin was 5.8% last quarter, down 6.9 points from the same quarter a year ago.
MSFT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $92.3B | +19% |
| Q2 2026 | $90B | +18% |
| Q1 2026 | $82.9B | +18% |
| Q4 2025 | $81.3B | +17% |
| Q3 2025 | $77.7B | +18% |
| Q2 2025 | $76.4B | +18% |
| Q1 2025 | $70.1B | +13% |
| Q4 2024 | $69.6B | +12% |
MSFT's revenue has grown year over year every quarter since late 2020: $92.3B last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 50% | +0.9 points |
| Q2 2026 | 45% | +0.2 points |
| Q1 2026 | 46% | +0.7 points |
| Q4 2025 | 47% | +1.6 points |
| Q3 2025 | 49% | +2.3 points |
| Q2 2025 | 45% | +1.8 points |
| Q1 2025 | 46% | +1.1 points |
| Q4 2024 | 45% | +1.9 points |
MSFT has the edge over CLBT on profitability, with a higher operating margin.
CLBT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $14.5M | -50% |
| Q1 2026 | $16.8M | -9.1% |
| Q4 2025 | $78.3M | +27% |
| Q3 2025 | $30M | -25% |
| Q2 2025 | $29M | +138% |
| Q1 2025 | $18.5M | +134% |
| Q4 2024 | $61.7M | +59% |
| Q3 2024 | $39.8M | +42% |
CLBT has the edge over MSFT on cash flow, with more consistent year-over-year improvement.
MSFT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $18.6B | -27% |
| Q2 2026 | $19.6B | -23% |
| Q1 2026 | $15.8B | -22% |
| Q4 2025 | $5.9B | -9.3% |
| Q3 2025 | $25.7B | +33% |
| Q2 2025 | $25.6B | +9.6% |
| Q1 2025 | $20.3B | -3.2% |
| Q4 2024 | $6.5B | -29% |
MSFT's free cash flow has been positive every quarter for seven years: $60B over the past year, down 23% from the year before.
CLBT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +711K shares |
| 1 year | +1.5% | +3.8M shares |
| 3 years | +34% | +64.7M shares |
| 5 years | +35% | +65.6M shares |
| Available history | +35% | +65.6M shares |
CLBT has 253M diluted shares, up 1.5% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | $11,000 |
CLBT hasn't bought back shares in the past year.
MSFT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -7M shares |
| 1 year | -0.3% | -20M shares |
| 3 years | -0.2% | -16M shares |
| 5 years | -1.6% | -121M shares |
| Available history | -3.2% | -245M shares |
MSFT has the edge over CLBT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.4B |
| Q2 2026 | $4.6B |
| Q1 2026 | $4.6B |
| Q4 2025 | $7.4B |
| Q3 2025 | $5.7B |
| Q2 2025 | $4.5B |
| Q1 2025 | $4.8B |
| Q4 2024 | $5B |
MSFT spent $21B buying back its own shares over the past year, up 5.2% from the year before.
CLBT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -1.0x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -0.8x | Net Cash |
| Q3 2023 | -0.8x | Net Cash |
| Q2 2023 | -0.6x | Net Cash |
| Q1 2023 | -0.4x | Net Cash |
| Q4 2022 | -0.3x | Net Cash |
| Q3 2022 | -0.4x | Net Cash |
CLBT has the edge over MSFT on leverage, with a lower net debt burden relative to earnings.
MSFT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | 0.1x | Very low |
MSFT's net debt is less than a year of its operating earnings (EBITDA).
CLBT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.7 | Neutral |
| Stochastic | 32.9 | Neutral |
CLBT's weekly RSI is 42 (neutral) and its Stochastic is 33 (neutral).
MSFT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.1 | Neutral |
| Stochastic | 68.0 | Neutral |
MSFT's weekly RSI is 62 (neutral) and its Stochastic is 68 (neutral).
CLBT PE vs Technology Sector
| Metric | CLBT | Sector median | Relative |
|---|---|---|---|
| PE | 47x | 28x | 67% above |
| PE % | 55 | 39 | 16 pts above |
CLBT is trading at 47x earnings, a 67% premium to the Technology sector's median of 28x, though its recent earnings include one-off gains.
MSFT PE vs Technology Sector
| Metric | MSFT | Sector median | Relative |
|---|---|---|---|
| PE | 27x | 28x | 2% below |
| PE % | 16 | 35 | 19 pts below |
MSFT has the edge over CLBT on valuation relative to its sector.
CLBT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.5 | 5.1% below |
| 20 week MA | $12.6 | 14% below |
| 50 week MA | $13.9 | 22% below |
| 100 week MA | $16.1 | 32% below |
| 200 week MA | $13.1 | 17% below |
CLBT is in a downtrend: it's below all five of its weekly moving averages, and 17% below its 200-week average.
MSFT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $524.7 | 0.3% below |
| 20 week MA | $484.8 | 7.9% above |
| 50 week MA | $446.9 | 17% above |
| 100 week MA | $453.8 | 15% above |
| 200 week MA | $411.5 | 27% above |
MSFT has the edge over CLBT on trend strength, trading above more of its moving averages.
CLBT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.66 | $10.5 | +8.8% |
| 2021 | $10.5 | $8.10 | -23% |
| 2022 | $8.10 | $4.18 | -48% |
| 2023 | $4.18 | $8.66 | +107% |
| 2024 | $8.66 | $22.2 | +156% |
| 2025 | $22.2 | $18.4 | -17% |
| 2026 YTD | $18.4 | $10.9 | -41% |
CLBT's yearly returns have swung widely, from +156% in 2024 to −48% in 2022. It's down 41% so far in 2026.
MSFT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $159.0 | $222.8 | +40% |
| 2021 | $222.8 | $334.7 | +50% |
| 2022 | $334.7 | $238.7 | -29% |
| 2023 | $238.7 | $376.0 | +58% |
| 2024 | $376.0 | $430.5 | +14% |
| 2025 | $430.5 | $487.7 | +13% |
| 2026 YTD | $487.7 | $523.0 | +7.2% |
MSFT has the edge over CLBT on returns for 2026, with the stronger performance.